Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qualiplante is a French private company that develops, produces, and commercializes molecular diagnostic kits for plant health testing rather than human therapeutics. Its products are designed to detect plant pathogens across crops such as grapevine, fruit trees, vegetables, and ornamentals, using PCR-based methods and related molecular workflows. The company positions itself as a provider of validated, easy-to-use plant disease testing solutions for laboratories and agricultural users. Qualiplante also markets compatible instrumentation such as a miniaturized thermal cycler and emphasizes scientific validation and partnerships in plant pathology. Overall, it is best categorized as an agritech/plant diagnostics company, not a biotech or pharma drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qualiplante.